Sofinnova News
Video: Sofinnova Partners 2024 annual general meeting
Related Strategy
CapitalRelated Strategy
CrossoverRelated Strategy
MD StartRelated Strategy
Digital MedicineRelated Strategy
Industrial BiotechRelated Strategy
TelethonRelated Strategy
BiovelocitaOur Annual General Meeting is a pivotal event that underscores the importance of collaboration and innovation in navigating our changing world, particularly in the current climate.
During this year's two-day event, our LPs, investment teams, and the CEOs of our portfolio companies shared stories of passion, perseverance, and the relentless pursuit of innovation to improve the health of people and the planet. These highlights remind us of the fundamentals we uphold in this period of constant change and uncertainty.
We extend our deepest gratitude to our LPs for their unwavering trust and support throughout the years. Their belief in our mission enables us to continue investing in groundbreaking science and innovation, which are essential in addressing our ever-changing world.
Check-out the video to get a glimpse of our 2024 Annual General Meeting:
Video of Sofinnova Partners 2024 Annual General Meeting
Related News
Alethio Therapeutics Raises $90 Million (£67 Million) in Oversubscribed Series A Financing to Advance a New Generation of Therapies for Myeloproliferative Neoplasms
BrightHeart Expands Its AI Platform in Europe to Bring Greater Confidence and Consistency to Prenatal Ultrasound
Sofinnova Partners promotes Javier Nunez-Vicandi to Partner, strengthening its Digital Medicine strategy
Qorium Becomes Reyva as Cultivated Leather Company Moves Towards Commercial Scale
Purespring Therapeutics advances kidney-targeted gene therapy PS-003 towards the clinic in X-linked Alport Syndrome